BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6228323)

  • 1. [Evaluation on cellular immunity in patients with gynecological tumors by lymphoblast transformation test].
    Liu WS; Hu XF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Aug; 5(4):257-8. PubMed ID: 6228323
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of lymphocyte transformation test in gynecological malignancies (author's transl)].
    Zhonghua Fu Chan Ke Za Zhi; 1979; 14(4):311-3. PubMed ID: 555895
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of phenol in PPD solutions on the results of cellular immunity tests].
    López-Santiago R; Aguilar-Santelises M; Jiménez-Zamudio L
    Rev Latinoam Microbiol; 1984; 26(1):53-60. PubMed ID: 6484355
    [No Abstract]   [Full Text] [Related]  

  • 4. [Application of phytohemagglutinin skin test to assess cell-mediated immunity in pregnancy and in patients with gynecologic tumors].
    Tang HJ
    Zhonghua Fu Chan Ke Za Zhi; 1982 Jul; 17(3):166-8. PubMed ID: 7172859
    [No Abstract]   [Full Text] [Related]  

  • 5. Prediction of survival in gynecological cancer based on immunological tests.
    Check IJ; Hunter RL; Rosenberg KD; Herbst AL
    Cancer Res; 1980 Dec; 40(12):4612-6. PubMed ID: 6449287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological deficiencies associated with malignant gynecological tumors].
    Laurentaci G; Maiorino R; Schonauer S; Favoino B; Loiudice L
    Minerva Ginecol; 1980 Apr; 32(4):303-7. PubMed ID: 6966773
    [No Abstract]   [Full Text] [Related]  

  • 7. The short effect of pelvic radiotherapy of gynecological cancers on humoral and cell mediated immunity.
    Bolla M; Favre M; Bensa JC; Lachet B
    Biomed Pharmacother; 1982; 36(3):139-44. PubMed ID: 6983894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of the immunosuppressive factor in the serum of patients with gynecologic tumors].
    Cai G; Liu GZ
    Acta Acad Med Wuhan; 1981; 1(2):56-7. PubMed ID: 7052264
    [No Abstract]   [Full Text] [Related]  

  • 9. Tryptophan degradation in patients with gynecological cancer correlates with immune activation.
    Schroecksnadel K; Winkler C; Fuith LC; Fuchs D
    Cancer Lett; 2005 Jun; 223(2):323-9. PubMed ID: 15896467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoimmunity in chronic liver diseases. II. Study of cellular immunity by lymphoblast transformation].
    Balázs M; Pár A; Palka I; Deák G; Jávor T
    Orv Hetil; 1972 May; 113(20):1055-8. PubMed ID: 5026129
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of levamisole on immunity in patients with gynecological carcinoma.
    Tosner J; Turková M; Fixa B
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1982; 25(5):525-34. PubMed ID: 6985393
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological studies in leprosy--II: Study of lymphoblast transformation to PHA in different types of leprosy patients.
    Singh PK; Ratna ; Jain PK; Mital VP
    Indian J Lepr; 1984; 56(1):30-5. PubMed ID: 6548242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Specific immune reactions in gynecologic neoplasms].
    Kitschke HJ; Stoldt H; Stoldt A; Krebs D
    Arch Gynakol; 1975 Nov; 219(1-4):523-5. PubMed ID: 1243460
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune status in patients cured of breast and gynaecological cancer.
    Haim N; Rudik L; Samuelly B; Mekori T; Robinson E
    Clin Oncol; 1981 Jun; 7(2):141-7. PubMed ID: 7249436
    [No Abstract]   [Full Text] [Related]  

  • 15. Study of cell mediated immune responsiveness to soluble egg antigen and phytohaemagglutinin using the lymphoblast transformation test in human schistosomiasis mansoni in Egypt.
    Khalil H; Fahmy MH; Ghanem MH; Said M; El Sawy M; Nofal M; Awadalla HN; Youssef M; Mucke D; Brock J; Bedwany R; Khalil T
    Rev Inst Med Trop Sao Paulo; 1981; 23(3):97-101. PubMed ID: 7280480
    [No Abstract]   [Full Text] [Related]  

  • 16. [Behavior of T-lymphocytes in patients with a gynecologic malignancy].
    Ressel M; Köhler G
    Zentralbl Gynakol; 1984; 106(17):1192-7. PubMed ID: 6333766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma.
    Arvin AM; Pollard RB; Rasmussen LE; Merigan TC
    J Clin Invest; 1980 Apr; 65(4):869-78. PubMed ID: 6244336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The studies of cellular immunity to gynecologic tumors with macrophage migration inhibition test.
    Kenjo T
    Keio J Med; 1974 Mar; 23(1):1-15. PubMed ID: 4473680
    [No Abstract]   [Full Text] [Related]  

  • 19. [Definition of immune status in patients with malignant gynecologic neoplasms].
    Koenig UD
    Arch Gynecol; 1979 Jul; 228(1-4):604-5. PubMed ID: 485501
    [No Abstract]   [Full Text] [Related]  

  • 20. [Controlled study of unspecific cellular immunity in cancer patients].
    Dominioni L; Dionigi R; Prati U; Cividini F; Cincera M; Pavesi L; Della Cuna GR
    Minerva Med; 1981 Mar; 72(12):733-40. PubMed ID: 6971418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.